Please Wait
Applying Filters...
menu
    • menu
    Abbvie Contract Manufacturing-PSE
    News
    IPAB stays revocation of Pharmacyclics’ patent on anti-cancer drug Ibrutinib

    23 Jun 2020

    // PHARMABIZ

    Patent for Pharmacyclic's cancer drug revoked on challenge by Laurus Labs

    23 Mar 2020

    // Gireesh Babu BUSINESS-STANDARD

    Swiss biotech ADC Therapeutics guns for $150M IPO

    09 Sep 2019

    // Ben Adams FIERCEBIOTECH

    Data Compilation
    #PharmaFlow

    Pharmacyclics VB RM

    Contact Supplier

    Website

    Pharma, Lab & Chemical Expo

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/cdmo-activity-tracker-bora-polpharma-make-acquisitions-evonik-euroapi-porton-announce-technological-expansions
    Menu

    Pharmacyclics

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    NEWS #PharmaBuzz

    read-more
    read-more
    IPAB stays revocation of Pharmacyclics’ patent on anti-cancer drug Ibrutinib
    IPAB stays revocation of Pharmacyclics’ patent on anti-cancer drug Ibrutinib

    23 Jun 2020

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=129058&sid=1

    PHARMABIZ
    23 Jun 2020
    Share Share
    Patent for Pharmacyclic's cancer drug revoked on challenge by Laurus Labs
    Patent for Pharmacyclic's cancer drug revoked on challenge by Laurus Labs

    23 Mar 2020

    // Gireesh Babu BUSINESS-STANDARD

    https://www.business-standard.com/article/companies/patent-for-pharmacyclic-s-cancer-drug-revoked-on-challenge-by-laurus-labs-120032100944_1.html

    Gireesh Babu BUSINESS-STANDARD
    23 Mar 2020
    Share Share
    Swiss biotech ADC Therapeutics guns for $150M IPO
    Swiss biotech ADC Therapeutics guns for $150M IPO

    09 Sep 2019

    // Ben Adams FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/swiss-biotech-adc-therapeutics-guns-for-150m-ipo

    Ben Adams FIERCEBIOTECH
    09 Sep 2019
    Share Share
    Pharma shells out $3B to doctors and hospitals—with Roche, Sanofi leading: CMS
    Pharma shells out $3B to doctors and hospitals—with Roche, Sanofi leading: CMS

    02 Jul 2019

    // Kyle Blankenship FIERCE PHARMA

    https://www.fiercepharma.com/pharma/big-pharma-hits-3b-payments-to-doctors-and-teaching-hospitals-cms

    Kyle Blankenship FIERCE PHARMA
    02 Jul 2019
    Share Share
    AstraZeneca's Calquence treads on Imbruvica's turf with second phase 3 CLL win
    AstraZeneca's Calquence treads on Imbruvica's turf with second phase 3 CLL win

    07 Jun 2019

    // Carly Helfand FIERCE PHARMA

    https://www.fiercepharma.com/pharma/astrazeneca-s-calquence-treads-imbruvica-s-turf-second-ph3-cll-win

    Carly Helfand FIERCE PHARMA
    07 Jun 2019
    Share Share
    AbbVie unveils Venclexta data
    AbbVie unveils Venclexta data

    04 Jun 2019

    // Carly Helfand FIERCE PHARMA

    https://www.fiercepharma.com/pharma/abbvie-unveils-venclexta-data-scored-lightning-fast-cll-combo-nod

    Carly Helfand FIERCE PHARMA
    04 Jun 2019
    Share Share